Akers Biosciences, Inc. logo
Akers Biosciences, Inc. AKER

Akers Biosciences, Inc. Financial Statements 2011-2026 | AKER

Annual Financial Statements Akers Biosciences, Inc.

2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

809 K 888 K 6.36 M 1.2 M 3.26 M 3.08 M 8 M 4.14 M - -

Shares

306 K 306 K 229 K 24.7 K 14.1 K 13.4 K 12.4 K 4.16 K - -

Net Income

-17.6 M -3.89 M -10.8 M -5.81 M -3.3 M -9.31 M -3.13 M -1.53 M -2.45 M -3.58 M

Revenue

- 1.58 M 1.67 M 3.93 M 2.96 M 2.12 M 4.43 M 3.58 M 1.52 M 1.79 M

EBITDA

-12.3 M -3.76 M -8.38 M -4.88 M -4.46 M -6.82 M -2.95 M -1.55 M -2.19 M -3.33 M

Operating Expenses

7.99 M 4.28 M 8.68 M 7.56 M 6.51 M 8.22 M 6.46 M 3.47 M 3.17 M 4.74 M

General and Administrative Expenses

- 3.73 M 5.67 M 4.08 M 3.01 M 4.03 M 3.98 M 1.52 M 1.49 M 3.28 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Akers Biosciences, Inc. AKER
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Akers Biosciences, Inc. plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Medical instruments industry

Issuer Price % 24h Market Cap Country
Atrion Corporation Atrion Corporation
ATRI
- - $ 810 M usaUSA
Baxter International Baxter International
BAX
$ 20.96 1.28 % $ 10.7 B usaUSA
Becton, Dickinson and Company Becton, Dickinson and Company
BDX
$ 204.28 -0.4 % $ 58.8 B usaUSA
Luminex Corporation Luminex Corporation
LMNX
- - $ 1.75 B usaUSA
ICU Medical ICU Medical
ICUI
$ 151.41 -0.16 % $ 3.69 B usaUSA
iRhythm Technologies iRhythm Technologies
IRTC
$ 183.34 -3.12 % $ 5.72 B usaUSA
Antares Pharma, Inc. Antares Pharma, Inc.
ATRS
- - $ 955 M usaUSA
Repro Med Systems Repro Med Systems
KRMD
$ 5.76 -0.95 % $ 263 M usaUSA
Cantel Medical Corp. Cantel Medical Corp.
CMD
- -1.18 % $ 3.4 B usaUSA
CRH Medical Corporation CRH Medical Corporation
CRHM
- - $ 282 M usaUSA
Masimo Corporation Masimo Corporation
MASI
$ 138.46 0.4 % $ 7.38 B usaUSA
Hill-Rom Holdings, Inc. Hill-Rom Holdings, Inc.
HRC
- -0.05 % $ 10.3 B usaUSA
Merit Medical Systems Merit Medical Systems
MMSI
$ 85.55 -8.19 % $ 4.98 B usaUSA
Nephros Nephros
NEPH
$ 4.88 -2.57 % $ 50.7 M usaUSA
Ekso Bionics Holdings Ekso Bionics Holdings
EKSO
$ 8.01 -2.2 % $ 161 M usaUSA
Varian Medical Systems, Inc. Varian Medical Systems, Inc.
VAR
- -0.02 % $ 16.3 B usaUSA
Alcon Alcon
ALC
$ 80.22 -0.51 % $ 40.4 B schweizSchweiz
Predictive Oncology Predictive Oncology
POAI
$ 6.96 3.0 % $ 38 M usaUSA
AtriCure AtriCure
ATRC
$ 42.52 0.27 % $ 2 B usaUSA
electroCore electroCore
ECOR
$ 5.39 7.16 % $ 29.7 K usaUSA
Haemonetics Corporation Haemonetics Corporation
HAE
$ 83.2 -0.99 % $ 4.19 B usaUSA
AngioDynamics AngioDynamics
ANGO
$ 9.99 -0.6 % $ 408 M usaUSA
Harvard Bioscience Harvard Bioscience
HBIO
$ 0.65 0.14 % $ 27.6 M usaUSA
The Cooper Companies The Cooper Companies
COO
$ 83.29 0.19 % $ 16.6 B usaUSA
LeMaitre Vascular LeMaitre Vascular
LMAT
$ 85.52 0.56 % $ 1.92 B usaUSA
Glaukos Corporation Glaukos Corporation
GKOS
$ 112.52 -1.49 % $ 5.45 B usaUSA
InfuSystem Holdings InfuSystem Holdings
INFU
$ 8.77 -2.23 % $ 181 M usaUSA
Isoray Isoray
ISR
- 0.03 % $ 108 M usaUSA
Utah Medical Products Utah Medical Products
UTMD
$ 59.75 1.75 % $ 217 M usaUSA
Intuitive Surgical Intuitive Surgical
ISRG
$ 583.99 -0.19 % $ 207 B usaUSA
Microbot Medical Microbot Medical
MBOT
$ 2.11 -3.44 % $ 21.5 M israelIsrael
Milestone Scientific Milestone Scientific
MLSS
$ 0.3 2.33 % $ 23.9 M usaUSA
NeuroMetrix NeuroMetrix
NURO
- 5.05 % $ 9.02 M usaUSA
Envista Holdings Corporation Envista Holdings Corporation
NVST
$ 23.54 -0.34 % $ 4.05 B usaUSA
OraSure Technologies OraSure Technologies
OSUR
$ 2.66 -0.19 % $ 198 M usaUSA
Pro-Dex Pro-Dex
PDEX
$ 41.4 0.24 % $ 136 M usaUSA
Pulse Biosciences Pulse Biosciences
PLSE
$ 15.04 2.17 % $ 722 M usaUSA
Repligen Corporation Repligen Corporation
RGEN
$ 167.79 0.82 % $ 9.35 M usaUSA
ResMed ResMed
RMD
$ 253.14 0.88 % $ 37 B usaUSA
BioLife Solutions BioLife Solutions
BLFS
$ 25.1 0.6 % $ 1.16 B usaUSA
STERIS plc STERIS plc
STE
$ 258.92 -0.68 % $ 25.5 B usaUSA
Stereotaxis Stereotaxis
STXS
$ 2.58 - $ 208 M usaUSA
Retractable Technologies Retractable Technologies
RVP
$ 0.77 0.47 % $ 23.1 M usaUSA
STAAR Surgical Company STAAR Surgical Company
STAA
$ 22.42 -0.36 % $ 1.1 B usaUSA
Teleflex Incorporated Teleflex Incorporated
TFX
$ 110.84 0.75 % $ 5.19 B usaUSA
West Pharmaceutical Services West Pharmaceutical Services
WST
$ 277.25 0.7 % $ 20.2 B usaUSA
DENTSPLY SIRONA DENTSPLY SIRONA
XRAY
$ 12.39 -0.76 % $ 2.52 B usaUSA